You can buy or sell GENE and other stocks, options, and ETFs commission-free!
Genetic Technologies Ltd Sponsored ADR, also called Genetic Technologies, is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia. The listed name for GENE is Genetic Technologies Ltd Sponsored ADR.
Fitzroy, Victoria (VIC)
52 Week High
52 Week Low